AcornMed Biotechnology Co., Ltd.
PrivateLast Round
Series B
Dec 27, 2022
Total Funding Raised
$42.79M
Company Overview
AcornMed Biotechnology Co., Ltd. is a precision medicine company that develops non-invasive genomic testing solutions for cancer screening, diagnosis, and monitoring.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AcornMed Biotechnology Co., Ltd. Comparables
Compare AcornMed Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
AcornMed Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 27, 2022 | ||||
| Series A | Apr 8, 2020 | ||||
| Angel | Jul 1, 2018 |
AcornMed Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sino-Ocean Capital | Series A |
| Pragmatic Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 27, 2022
$29M round led by Pragmatic Capital.
- Apr 8, 2020
$14.14M round led by Sino-Ocean Capital.
AcornMed Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AcornMed Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is AcornMed Biotechnology Co., Ltd. a public or private company?
AcornMed Biotechnology Co., Ltd. is a private company.
What is the current stock price of AcornMed Biotechnology Co., Ltd.?
AcornMed Biotechnology Co., Ltd. is a private company with no public stock price. Caplight tracks AcornMed Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is AcornMed Biotechnology Co., Ltd. worth (valuation)?
Valuation information for AcornMed Biotechnology Co., Ltd. is not publicly available.
Can I buy AcornMed Biotechnology Co., Ltd. stock?
AcornMed Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AcornMed Biotechnology Co., Ltd.'s last funding round?
AcornMed Biotechnology Co., Ltd.'s most recent funding round was Series B on December 27, 2022.
Who are the main investors in AcornMed Biotechnology Co., Ltd.?
Key investors in AcornMed Biotechnology Co., Ltd. include Sino-Ocean Capital.
Will AcornMed Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for AcornMed Biotechnology Co., Ltd..
How can I track AcornMed Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AcornMed Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.